ZHONG JI LS subsidiary plans to collaborate with AVIC Health on longevity testing, longevity management, and other businesses

Zhitong
2025.08.08 08:54
portai
I'm PortAI, I can summarize articles.

ZHONG JI LS's wholly-owned subsidiary Hongfeng Development has signed a memorandum of cooperation with AVIC Health to jointly carry out longevity testing and management services, providing related health services. AVIC Health is a comprehensive health management enterprise with over 600,000 registered clients. The board of directors believes that the health and longevity science market has broad prospects, and the cooperation will help expand the company's revenue sources and promote business development

According to the announcement from ZHONG JI LS (00767), on August 8, 2025, the company's wholly-owned subsidiary, Hongfeng Development Co., Ltd. (Hongfeng Development), entered into a memorandum of cooperation with Shenzhen AVIC Health Fashion Group Co., Ltd. (AVIC Health). Under this memorandum, Hongfeng Development and AVIC Health will jointly cooperate in longevity testing, longevity management, and other businesses, providing customers with longevity bioproducts, longevity medical testing, health consulting services, and longevity management products and services in the big health industry.

AVIC Health is a limited company established in China in 1998. It is a national high-tech enterprise that integrates sports health, health management, and comprehensive medical services, providing customers with specialized, personalized, and comprehensive health solutions. The group currently has over 600,000 registered customers and provides specialized and systematic employee health management services to more than 300 world-class enterprises, serving millions of people annually. The group adheres to a business model centered on "innovation in technology and services," leveraging industry-leading technological advantages to actively explore and innovate in the big health field, making it a leading enterprise in China's health management service industry.

The board believes that the market prospects for health longevity science are broad, as it has been observed that wealthy clients globally are more willing to accept and spend on longevity science applications to enhance their overall health and immune status, and promote their physical rejuvenation.

In addition, the signing of the memorandum and its cooperation matters align with the group's development strategy and plan for longevity science business, which will benefit the group's future business development. The board believes that potential cooperation matters will further enhance the group's layout in the field of longevity science diagnostics and medical services, opening up new sources of revenue in longevity science for the company, with the aim of bringing more stable and sustainable growth in revenue for the group in the long term